DTDaniele Tradati

Daniele Tradati

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Daniele Tradati has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Transtibial versus anteromedial transportal femoral tunnel in single-bundle anterior cruciate ligament reconstruction: a systematic review and meta-analysis of prospective randomized controlled trials

    by M. Alessio-Mazzola, D. Tradati, M. Slongo, A. Belluati, G. Placella, V. Salini

    The purpose of this study was to systematically review and meta-analyze randomized controlled trials (RCTs) reporting the comparative clinical and functional outcomes, postoperative complications, and radiological outcomes of single-bundle anterior cruciate ligament reconstruction (ACLR) performed using the transtibial (TT) approach or anteromedial (AM) technique. A systematic review of the literature was performed according to Cochrane and PRISMA guidelines. RCTs comparing TT and AM techniques were considered only. The quality of the studies was defined using the GRADE system, and the risk of bias was assessed with the RoB 2 tool. The primary endpoint was to systematically review and meta-analyze the clinical outcomes, residual laxity and failure rate of both AM and TT techniques. In the current meta-analysis 13 RCTs involving 989 patients who underwent arthroscopic single-bundle ACLR (486 TT and 503 AM) were included. Patients undergoing AM technique resulted in higher objective-IKDC (p < 0.001) and Lysholm scores (p = 0.002), despite a lower incidence of pathological anterior tibial translation (p < 0.001) and positive pivot-shift test (p < 0.001). No differences were detected in IKDC subjective score (p = 0.26), Tegner activity scale (p = 0.18) and graft failure (p = 0.07). ACL reconstruction through AM portal technique provides better clinical outcomes and lower incidence of residual rotational and anteroposterior laxity in comparison with the TT technique. No statistically significant difference in subjective outcomes and graft failure was reported.


  • Open Access

    Cell‐free osteochondral scaffolds provide a substantial clinical benefit in the treatment of osteochondral defects at a minimum follow‐up of 5 years

    by Martina Ricci, Daniele Tradati, Alessio Maione, Francesco Mattia Uboldi, Eva Usellini, Massimo Berruto

    Purpose: The treatment of osteochondral lesions is challenging and no consensus has been established about the best option for restoring both cartilage and subchondral bone. Multilayer collagen‐hydroxyapatite scaffolds have shown promising clinical results, but the outcome at a follow‐up longer than 5 years still has to be proved. The aim was to evaluate the clinical outcome of patients with a knee isolated osteochondral lesion treated with a biomimetic three‐layered scaffold at a minimum 5 years of follow‐up.Methods: Twenty‐nine patients (23 males and 6 females, mean age 31.5 ± 11.4 years) were evaluated retrospectively before surgery, at 1 and 2 years and at last follow‐up (FU). Visual Analog Scale (VAS) for pain, International Knee Documentation Committee (IKDC) Subjective Score, Tegner‐Lysholm Knee Scoring Scale and Tegner Activity Level Scale were collected. Mean FU was 7.8 ± 2.0 years (min 5.1 ‐ max 11.3). The etiology of the defect was Osteochondritis Dissecans or osteonecrosis (17 vs 12 cases).Results: At 12 months FU the IKDC score improved from 51.1 ± 21.7 to 80.1 ± 17.9 (p < 0.01), Tegner Lysholm Score from 59.9 ± 17.3 to 92.5 ± 9.0 (p < 0.01), VAS from 6.1 ± 2.1 to 1.7 ± 2.3 (p < 0.01) and Tegner Activity Level Scale from 1.6 ± 0.5 to 4.9 ± 1.7 (p < 0.01). The results remained stable at 24 months, while at last FU a statistically significant decrease in IKDC, Tegner Lysholm and Tegner Activity Scale was recorded, though not clinically relevant. Patients under 35 achieved statistically better outcomes.Conclusions: The use of a cell‐free collagen‐hydroxyapatite osteochondral scaffold provides substantial clinical benefits in the treatment of knee osteochondral lesions at a minimum follow‐up of 5 years, especially in patients younger than 35 years.Level of evidence: Level IV.


  • Open Access

    AMIC—Autologous Matrix-Induced Chondrogenesis Technique in Patellar Cartilage Defects Treatment: A Retrospective Study with a Mid-Term Follow-Up

    by Daniele Tradati, Paola De Luca, Alessio Maione, Francesco Mattia Uboldi, Piero Volpi, Laura de Girolamo, Massimo Berruto

    Background: Knee cartilage defects can be retrieved in 60% of patients undergoing knee arthroscopy, especially in the patellofemoral joint. Different techniques have been proposed to treat patellar defects, although most of them are associated with short-term results. In this study Autologous Matrix Induced Chondrogenesis (AMIC), combining subchondral microfractures with a collagen membrane (type I and III collagen), was used in the treatment of isolated patellar cartilage defects. Methods: Twenty-four patients were enrolled in this retrospective study. Subjective-International Knee Documentation Committee (IKDC), Visual Analog Scale for Pain (VAS), and Kujala score were collected at 1, 3, 6, and 12 months after surgery, whereas the Tegner Activity Level Scale was determined preoperatively and at final follow-up (final-FU). The same postoperative management and rehabilitation protocol was adopted for all the patients. Results: Fourteen patients met the inclusion–exclusion criteria and were evaluated at a mean final-FU of 68.2 months (range 25.4–111.2). At 12 months, Kujala, IKDC, and VAS scores significantly increased in comparison to the preoperative assessment, whereas no statistically significant differences were reported between 12 months and final follow-up. Conclusion: This study demonstrated very good results throughout the follow-up, also in sports patients. The AMIC technique, together with an adequate rehabilitation protocol, can be considered as a reliable one-step alternative for the treatment of large isolated patellar cartilage defects.


  • Closing‐wedge high tibial osteotomy, a reliable procedure for osteoarthritic varus knee

    by M. Berruto, A. Maione, D. Tradati, P. Ferrua, F. M. Uboldi, E. Usellini

    Purpose: The purpose of this study was to analyze the long‐term clinical and radiological outcomes of patients who underwent closing‐wedge High Tibial Osteotomy (HTO) for the treatment of medial compartment osteoarthritis and to evaluate the conversion rate to knee arthroplasty.Methods: A retrospective, non‐randomized, monocentric study was performed in our Institution considering 166 patients between 1989 and 2012. The final population was composed by 82 patients (94 knees), median age at time of operation was 53 (range 45–73) years. All patients were evaluated clinically (HSS Score, Tegner Scale, VAS and Crosby–Insall Grading) and radiographically (osteoarthritis staging, hip–knee–ankle (HKA) angle, tibial slope and metaphyseal varus).Results: Mean follow‐up was 11.9 ± 7.2 years. HSS Score increased significantly from 70.8 ± 10 to 93.2 ± 9.1 (p < 0.05) instead Tegner Scale increased from 1.3 ± 0 (range 1–4) to 2.8 ± 0.7 (range 2–6) at the last control (n.s.); VAS score significantly decreased from 7.9 ± 1.4 to 1.6 ± 1.1 (p < 0.05) at last follow‐up. According to the Crosby–Insall Grading System, 80 patients (97.4%) reported excellent–good results. HKA angle decreased from 6.9° ± 3.5 to 2.6° ± 2.6 (p < 0.01), tibial slope decreased from 10.1° ± 1.4 to 6.8° ± 2.1 (p < 0.05) and finally the metaphyseal varus decreased from 4.2° ± 0 to 2.1° ± 1.2 (n.s.) at the last follow‐up. Adverse events were reported in 4.8%. Osteotomy survivorship rate resulted 92% at 10 years, 82% at 15 years and 80% at 20 years. Sixteen revisions (9.6%) were reported at a mean period of 12.8 years.Conclusions: CW‐HTO is a valid option for medial osteoarthritis treatment, with successful results in both clinical and radiological outcomes.Level of evidence: IV.


  • Open Access

    Use of an Elastomeric Knee Brace in Patellofemoral Pain Syndrome: Short-Term Results

    by Francesco Mattia Uboldi, Paolo Ferrua, Daniele Tradati, Pietro Zedde, Jim Richards, Andrea Manunta, Massimo Berruto

    Purpose This article verifies the effectiveness of a new brace on patellofemoral pain syndrome (PFPS) in adjunct to a specifically developed rehabilitation program. Methods Two groups of 30 patients with PFPS were prospectively and randomly allocated to a rehabilitation protocol, with (group A) or without (group B) the use of a specific brace. All the patients were assessed at 3, 6, and 12 months using the disease-specific Kujala scale and a visual analog scale (VAS) for pain; time to return to sport and patient satisfaction with the brace were also recorded. Results Kujala scale's values showed constant and progressive improvement. The mean score at 6 months was 79.8 ± 6.8 points in group A and 76.8 ± 8.6 in group B, rising at 12 months to 80.9 ± 7.5 in group A and 78.4 ± 8.3 in group B. VAS scores significantly differed (p < 0.05) between the two groups at both 6 and 12 months; the score recorded at 12 months was 0.9 ± 1.3 in the brace-treated group and 1.8 ± 1.6 in the controls. The patients who used a brace showed a quicker return to sports and 75% of the patients in this group were satisfied. Conclusion All the scores improved progressively in both groups. The most significant improvement concerned pain, showing that the brace used in this study may allow a better subjective outcome and a quicker return to sport. Level of Evidence Level II, prospective randomized controlled trial.


  • Long-term follow-up evaluation of autologous chondrocyte implantation for symptomatic cartilage lesions of the knee: A single-centre prospective study

    by M. Berruto, P. Ferrua, S. Pasqualotto, F. Uboldi, A. Maione, D. Tradati, E. Usellini


  • Open Access

    Suture Anchors Fixation in MPFL Reconstruction using a Bioactive Synthetic Ligament

    by Massimo Berruto, Paolo Ferrua, Daniele Tradati, Francesco Uboldi, Eva Usellini, Bruno Michele Marelli

    Medial patellofemoral ligament (MPFL) reconstruction has a key role in patellofemoral instability surgery. Many surgical techniques have been described so far using different types of grafts (autologous, heterologous, or synthetic) and fixation techniques. The hereby described technique for MPFL reconstruction relies on the use of a biosynthetic graft (LARS Arc Sur Tille, France). Fixation is obtained by means of suture anchors on the patellar side and a resorbable interference screw on the femoral side locating the insertion point according to Schottle et al. An early passive range of motion (ROM) recovery is fundamental to reduce the risk of postoperative stiffness; a partial weight bearing with crutches is allowed until 6 weeks after the surgery. In our experience, the use of a biosynthetic graft and suture anchors provides stable fixation, minimizing donor site morbidity and reducing the risk of patellar fracture associated with transosseous tunnels. This technique represents a reliable and reproducible alternative for MPFL reconstruction, thereby minimizing the risk of possible complications.


  • Patellofemoral knee arthroplasty

    by Massimo Berruto, Daniele Tradati, Paolo Ferrua, Alessio Maione, Eva Usellini

    Patellofemoral osteoarthritis (OA) is a common degenerative disease present in 10%-25% of patients presenting symptomatic knee OA. It can be found isolated or secondary to inflammatory joint diseases, patellar fractures and patellar instability. Anatomical abnormalities such as patella alta, altered patellar tilt and trochlear dysplasia can be identified as predisposing factors in patellofemoral OA etiopathology. In symptomatic patients with advanced stages isolated patellofemoral OA unicompartmental patellofemoral arthroplasty (PFA) is nowadays considered as the gold standard treatment. First reported by McKeever in 1955, PFA underwent a constant evolution in term of design and surgical techniques. Two kinds of prosthetic design are now available: resurfacing (so called inlay), in which the native trochlear shape and orientation remain unchanged with high bone preservation, and trochlear cutting (so called onlay) characterized by a wider asymmetrical trochlea with a higher level of patellar constraint. The success of replacement depends mainly on good patient selection and respect of relative and absolute contraindications. The outcomes are heterogeneous: recent studies about inlay generation showed a high revision rate (28%) at 6 years of follow-up. Onlay implants demonstrated a greater percentage of good to excellent results and survivorship, albeit inferior if compared to total knee arthroplasty. Early failure may be correlated to unexplained pain, progression of osteoarthritic process to femorotibial compartments and patellar maltracking, and late failure main cause remains progression of OA, followed by aseptic loosening and residual pain. In conclusion there is still no consensus for PFA indications and further long term and randomized studies are needed to assess the clinical benefits and long-term survivorship of this kind of implant.

  • Synovitis of the Knee

    by Massimo Berruto, Antonella Murgo, Paolo Ferrua, Francesco Uboldi, Daniele Tradati, Stefano Pasqualotto, Bruno Michele Marelli